Terms: = Thyroid cancer AND DDR2, NTRKR3, 4921, ENSG00000162733, Q16832, MIG20a, TYRO10
4 results:
1. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract] [Full Text] [Related]
2. Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.
Vella V; Malaguarnera R; Nicolosi ML; Morrione A; Belfiore A
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118522. PubMed ID: 31394114
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.
Santoni M; Guerra F; Conti A; Lucarelli A; Rinaldi S; Belvederesi L; Capucci A; Berardi R
Cancer Treat Rev; 2017 Sep; 59():123-131. PubMed ID: 28818671
[TBL] [Abstract] [Full Text] [Related]
4. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.
Rodrigues R; Roque L; Espadinha C; Pinto A; Domingues R; Dinis J; Catarino A; Pereira T; Leite V
Oncol Rep; 2007 Oct; 18(4):917-26. PubMed ID: 17786355
[TBL] [Abstract] [Full Text] [Related]